Opening Asia for Russia

Over 275.3 million doses of COVID-19 vaccines already administered in China

04.05.2021 38 просмотров

In China, as of May 2, more than 275.3 million doses of COVID-19 vaccines have been administered, according to the National Health Commission of the People's Republic of China.

In order to bring convenience and efficiency to the country, China has taken a number of measures, such as the deployment of mobile vaccination stations that offer one-stop registration, disinfection and vaccination services.

Labor Day, which runs from May 1st to May 5th, and people are encouraged to get vaccinated against coronavirus as early as possible.

China Vaccination 5.jpg

During the May Day holiday, doctors and volunteers are still working overtime to speed up the mass vaccination process.

So, in Beijing, as of May 1, more than 14.55 million people were vaccinated against COVID-19, which means that almost 25.03 million doses of the drug were administered in the Chinese capital, according to the Beijing Commission on

China Vaccination 3.jpg

Qingdao city (Prov. In Shandong, East China), four vaccination rooms have been installed to simultaneously meet the needs of residents from six nearby neighborhoods.

And at three vaccination sites in Zhuhai, Fujian Province, East China, community workers and volunteers are also stepping up advocacy efforts vaccination.

China Vaccination 2.jpg

In the city of Guangzhou (Guangdong Province, South China), young medical workers born in the 1990s are becoming the main force at vaccination points. On public holidays, they operate from 08:00 to 21:00.

China launched a mass vaccination program last December, prioritizing high-risk groups, including medical workers, people working or studying abroad, and workers cold chain, as well as key areas at high risk of COVID-19 infection.

China Vaccination 1.jpg

So far, China has approved four COVID-19 vaccines and one more has been approved for emergency use. On December 30, 2020, a vaccine developed by Chinese pharmaceutical company Sinopharm became the first drug to receive conditional approval in the country.

The country aims to vaccinate 70%-80% of its population, according to China's Center for Disease Control and Prevention. by the end of this year or by the middle of 2022.

Новости партнёров